Screener
Dyne Therapeutics, Inc. DYN Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Dyne Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The source filing: Dyne Therapeutics, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 7:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-215702
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 29,211 | 37,548 |
| Vendor financing arrangement | 6,224 | — |
| Lease liabilities | 5,033 | 4,995 |
| Total current liabilities | 51,249 | 50,625 |
| Long-term debt, net | 149,375 | 148,921 |
| Lease liabilities, net of current portion | 14,271 | 15,283 |
| Total liabilities | 214,895 | 214,829 |
| Stockholders’ equity |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Dyne Therapeutics, Inc.'s total current liabilities?
- Dyne Therapeutics, Inc. (DYN) reported total current liabilities of $51.25M in Q1 2026.
- How has Dyne Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Dyne Therapeutics, Inc.'s total current liabilities increased by 51.3% year-over-year, from $33.88M to $51.25M.
- What is the long-term trend for Dyne Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Dyne Therapeutics, Inc.'s total current liabilities has grown at a 35.8% compound annual growth rate (CAGR), from $10.97M to $50.63M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.
Ask your AI about Dyne Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude